Manulife Finl Stock Price, News & Analysis

Manulife Financial (NYSE: MFC) priced a U.S. public offering of U.S.$1,000,000,000 aggregate principal amount of 4.986% senior notes due 2035 at 100% on December 2, 2025. The offering was made under a prospectus supplement dated December 2, 2025, to a registration statement declared effective by the SEC on September 29, 2025.

The company intends to use net proceeds for general corporate purposes, which may include future refinancing. BofA Securities, Citigroup, J.P. Morgan and Morgan Stanley are joint book‑running managers. The securities will not be offered or sold in Canada.

Manulife (TSX: MFC, NYSE: MFC) announced that Colin Simpson, Chief Financial Officer, will participate in a fireside chat at the Desjardins Toronto Conference on Tuesday, November 25, 2025 at 1:45 p.m. ET.

A live webcast will be available via Manulife's investor relations website and a replay will be accessible for 90 days after the session.

Manulife (TSX: MFC) announced that Phil Witherington, President and Chief Executive Officer, will participate in a fireside chat with TD Securities analyst Mario Mendonca on Wednesday, November 19, 2025 at 9:00 a.m. ET.

The discussion will cover the company's recent business performance and refreshed enterprise strategy. A live webcast and a replay will be available on Manulife's Investor Relations website, with the replay accessible for three months.

Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) announced that Hai Ling will join its Board of Directors effective January 1, 2026. Mr. Ling is President for Asia Pacific, Europe, the Middle East and Africa at Mastercard and has held senior roles at Bank of America and HSBC.

Mr. Ling holds a Doctor of Humane Letters, a Bachelor of Science in Business Administration and an MBA from University of Chicago Booth School of Business. He will serve on Manulife's Audit Committee and Corporate Governance and Nominating Committee.

Board chair Don Lindsay said Mr. Ling's financial services and Asia market experience will support oversight of Manulife's strategy and operations.

Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) declared a quarterly common share dividend of C$0.44 per share, payable on and after December 19, 2025 to shareholders of record at the close of business on November 26, 2025.

The company said dividends reinvested under its Canadian and U.S. Dividend Reinvestment and Share Purchase Plans will be satisfied by purchasing common shares on the open market, with the purchase price based on the average actual cost and no applicable discounts.

Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) declared quarterly dividends on multiple non‑cumulative preferred share series, payable on or after December 19, 2025 to holders of record at the close of business on November 26, 2025.

Declared per‑share amounts include: Class A Series 2 $0.29063, Class A Series 3 $0.28125, Class 1 Series 3 $0.14675, Class 1 Series 4 $0.254363, Class 1 Series 9 $0.373625, Class 1 Series 11 $0.384938, Class 1 Series 13 $0.396875, Class 1 Series 15 $0.360938, Class 1 Series 17 $0.346375, Class 1 Series 19 $0.323063, and Class 1 Series 25 $0.371375.

Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) reported 3Q25 results on Nov 12, 2025, delivering record core earnings of $2.0 billion (up 10% on a CER basis) and core EPS of $1.16 (up 16% vs. 3Q24). Net income attributed to shareholders was $1.8 billion, roughly in line with 3Q24. Key commercial metrics: new business CSM +25%, NBV +11%, and APE sales +8%. Segment results included strong Asia and Canada performance, Global WAM core earnings +9% but net outflows of $6.2 billion, and U.S. core earnings -20%. Capital metrics: LICAT ratio 138% and adjusted book value per share $38.22 (+12% YoY). Strategic moves include completion of the Comvest Credit Partners acquisition (75%) and agreements to acquire Schroders Indonesia and a 50:50 life JV with Mahindra to enter India.

Manulife (MFC) announced the launch of the Longevity Institute on November 12, 2025, backed by a $350 million commitment through 2030 to advance research, advocacy, innovation, and community investments that aim to extend healthy years and improve financial resilience.

Initial actions include partnerships with the Milken Institute and National Institute on Ageing, global Longevity Symposiums (including John Hancock events in the U.S.), and expansion of the Longevity Preparedness Index. The Institute will operate as John Hancock Longevity Institute in the United States and build on Manulife’s work serving over 36 million customers.

Manulife (MFC) announced a refreshed enterprise strategy on Nov 12, 2025 with five elevated priorities aimed at sustainable, long-term growth: Winning Team and Culture; Diversified Business Portfolio; Empowering Customer Health, Wealth & Longevity; AI-Powered Organization; and Superior Distribution.

Key numeric targets include a core ROE of 18%+ by 2027, $22 billion+ cumulative remittances for 2024–2027, and an Asia core earnings contribution target of 50%. Manulife committed $350 million through 2030 to a new Longevity Institute and announced planned entry into the India insurance market via a JV with Mahindra (subject to regulatory approvals).